Literature DB >> 16960290

Ventriculo-lumbar perfusion in acute ischemic stroke.

Rodney D Bell1, Barbara L Powers, David Brock, J Javier Provencio, Adam Flanders, Ronald Benetiz, Robert Rosenwasser, Jamie Strause, Glenn Frazer, Michael S Kramer, David Hesson, James Barnitz, J L Osterholm.   

Abstract

INTRODUCTION: Effective treatment for severe ischemic stroke continues to be largely an unmet medical need. Using a nonvascular (paravascular cerebrospinal fluid) pathway to provide oxygen and nutrients to ischemic tissues may be a means of treating this disease. The primary objective of this study was to evaluate the safety and technical feasibility of ventriculo-lumbar perfusion with the oxygenated fluorocarbon nutrient emulsion (OFNE) perfusion system in the treatment of patients with severe hemispheric cerebral ischemia.
RESULTS: Four patients were enrolled in this pilot study. At admission, patients' National Institutes of Health Stroke Scale scores ranged from 16 to 24. The perfusion pathway was successfully established in all four patients. Maximum perfusion rates varied from 25 to 40 mL/minute; total volume perfused over the 24-hour period ranged from 30.6 to 45.8 L. ICP ranged from -3 to 16 mmHg during the perfusion. The 24-hour perfusion was successfully completed in all four patients with no serious adverse events during the perfusion.
CONCLUSION: It is technically feasible and safe to establish a ventriculo-lumbar perfusion pathway using a specially designed lumbar drainage catheter and to control intracranial pressure while perfusing large volumes of OFNE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960290     DOI: 10.1385/NCC:5:1:21

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  43 in total

1.  Rapid solute transport throughout the brain via paravascular fluid pathways.

Authors:  M L Rennels; O R Blaumanis; P A Grady
Journal:  Adv Neurol       Date:  1990

Review 2.  rtPA in acute ischemic stroke: European perspective.

Authors:  W Hacke
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

3.  American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors.

Authors:  R L Sacco; E J Benjamin; J P Broderick; M Dyken; J D Easton; W M Feinberg; L B Goldstein; P B Gorelick; G Howard; S J Kittner; T A Manolio; J P Whisnant; P A Wolf
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

4.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  ICP monitoring: complications and associated factors.

Authors:  M J Rosner; D P Becker
Journal:  Clin Neurosurg       Date:  1976

7.  Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction.

Authors:  S Schwab; S Schwarz; M Spranger; E Keller; M Bertram; W Hacke
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

8.  Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction.

Authors:  T Yamaguchi; K Minematsu; J Choki; M Ikeda
Journal:  Jpn Circ J       Date:  1984-01

9.  'Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus.

Authors:  K Minematsu; T Yamaguchi; T Omae
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  A reproducible experimental model of focal cerebral ischemia in the cat.

Authors:  B Bose; J L Osterholm; R Berry
Journal:  Brain Res       Date:  1984-10-08       Impact factor: 3.252

View more
  2 in total

Review 1.  Therapeutic hypothermia for ischemic stroke; pathophysiology and future promise.

Authors:  Kota Kurisu; Midori A Yenari
Journal:  Neuropharmacology       Date:  2017-08-19       Impact factor: 5.250

Review 2.  In cold blood: intraarteral cold infusions for selective brain cooling in stroke.

Authors:  Elga Esposito; Matthias Ebner; Ulf Ziemann; Sven Poli
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.